VaxSyna, Inc Email Format
Research ServicesBoston, United States2-10 Employees
VaxSyna is developing a novel vaccine platform that is highly immunogenic, thermally stable and is an easily modifiable platform to rapidly develop vaccines and therapeutics to address infectious diseases. Our leading products are vaccines targeting Herpes simplex virus and HPV.